J7634 – Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7634
- Long description
- Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
- Short description
- Budesonide comp con
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
D1GDrugs Administered through DME- Added
- January 1, 2007
- Last change
- January 1, 2007 – No change
Frequently asked questions
What is HCPCS code J7634?
J7634 is a HCPCS Level II code for budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram.
Does Medicare cover J7634?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7624 – Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
- J7627 – Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
- J7628 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7631 – Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7632 – Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7633 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
- J7635 – Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636 – Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637 – Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638 – Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7639 – Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7640 – Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
- J7641 – Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
- J7642 – Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.